as seen on

All general sessions were streamed LIVE on Facebook

GENERAL SESSIONS – DAY 1

Trigriluzole: A Phase 2/3 Randomized Controlled Trial in Patients with Spinocerebellar Ataxia – Robert Berman, MD

Clinical vs. Basic Science Research – Harry Orr, PhD and George (Chip) Wilmot, MD, PhD

NAF Update – Bill Sweeney, NAF President

Living with Ataxia – Moderator: Kyle Bryant; Panelists: Jonas Cepkauskas, Cathy DeCrescenzo, and Linda Snider, MD

Barriers to Exercise – Jennifer Millar, MS, PT and Jennifer Keller, MSPT

FRDA and Other Childhood Ataxias – David Lynch, MD, PhD

Genetic Testing – You Need to Get Tested: Here’s Why – Jeremy Schmahmann, MD

Ataxia Investigators Meeting (AIM) Highlights – Gülin Öz , PhD and Albert LaSpada, MD, PhD, FACMG

Management of Ataxia – Moderator: John W. Day, MD, PhD; Panelists: Amanda Gallagher, MA, CCC-SLP, Jennifer Keller, MSPT, and Liana Rosenthal, MD

Home Safety Based Modifications – Jessica Wilchinski, MA, OT R/L and Marlena Casey, OT R/L, CLT